Literature DB >> 8229110

Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.

G Danan1, C Benichou.   

Abstract

Despite the great number of methods proposed, assessing the causal role of a drug in the occurrence of an adverse medical event remains one of the most controversial issues. Qualifying terms for criteria, such as "compatible", "suggestive" of "inconclusive", have never been strictly defined, leading to low reproducibility. Weights of the criteria are usually not adapted to the injured organ, decreasing the specificity of the method. In this paper, a new method for drug causality assessment is described. Contents and limits of the criteria have been defined by experts convened to organ-oriented international consensus meetings. Additional criteria have been introduced and weights attributed. The method was applied to reports of acute liver injuries. The reproducibility was tested by an independent team. The validity of this novel method is studied in the following paper, based on an original approach using reports with positive rechallenge as external standard.

Entities:  

Mesh:

Year:  1993        PMID: 8229110     DOI: 10.1016/0895-4356(93)90101-6

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  371 in total

1.  Hepatotoxicity in patients with cirrhosis, an often unrecognized problem: lessons from a fatal case related to amoxicillin/clavulanic acid.

Authors:  R J Andrade; M I Lucena; M C Fernández; J L Vega; R Camargo
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

Review 2.  Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy.

Authors:  Shannan R Tujios; William M Lee
Journal:  Liver Int       Date:  2017-09-18       Impact factor: 5.828

3.  Jaundice due to suspected statin hepatotoxicity: a case series.

Authors:  Ottar M Bergmann; Gudjon Kristjansson; Jon G Jonasson; Einar S Björnsson
Journal:  Dig Dis Sci       Date:  2011-11-11       Impact factor: 3.199

4.  Herbal and dietary supplement-induced liver injury.

Authors:  Jonathan M Fenkel; Victor J Navarro
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

5.  A safety grading scale to support dose escalation and define stopping rules for healthy subject first-entry-into-man studies: some points to consider from the French Club Phase I working group.

Authors:  Michel Sibille; Alain Patat; Henri Caplain; Yves Donazzolo
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

Review 6.  Drug-induced liver disorders: implications for drug development and regulation.

Authors:  N Kaplowitz
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

7.  Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs.

Authors:  Sandra L Kane-Gill; Elizabeth A Forsberg; Margaret M Verrico; Steven M Handler
Journal:  Drug Saf       Date:  2012-08-01       Impact factor: 5.606

Review 8.  [Morphology of drug induced liver damage].

Authors:  H-U Kasper; U Drebber; I Hirsch; H P Dienes
Journal:  Pathologe       Date:  2006-05       Impact factor: 1.011

Review 9.  Drug-induced steatohepatitis.

Authors:  Vaishali Patel; Arun J Sanyal
Journal:  Clin Liver Dis       Date:  2013-09-04       Impact factor: 6.126

10.  Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Authors:  Naga Chalasani; Robert J Fontana; Herbert L Bonkovsky; Paul B Watkins; Timothy Davern; Jose Serrano; Hongqiu Yang; James Rochon
Journal:  Gastroenterology       Date:  2008-09-17       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.